CN Patent

CN108283000B — γ-羟基丁酸的前药及其组合物和用途

Assigned to XWPharma Ltd · Expires 2021-04-13 · 5y expired

What this patent protects

本申请公开了γ‑羟基丁酸的前药及其组合物和用途。

USPTO Abstract

本申请公开了γ‑羟基丁酸的前药及其组合物和用途。

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: CN108283000B
Jurisdiction: CN
Classification: —
Expires: 2021-04-13
Drug substance claim: No
Drug product claim: No
Assignee: XWPharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.